News
News | Inspection teams from the National Institute for Food and Drug Control, Zhejiang Provincial Institute of Drug Control, and Taizhou Municipal Institute of Drug Control visit Wanbangde for research and guidance
Date:
02 Jun,2023
On May 31, experts Wang Sijin and Wang Ganggang from the China Institute of Food and Drug Control (referred to as CFDC), along with Deputy Director Zheng Xiaoling from the Zhejiang Provincial Institute of Food and Drug Control (referred to as Zhejiang Provincial IFDC), and Vice President Hong Liang from the Taizhou Institute of Pharmaceutical Inspection (referred to as Taizhou IFIC), visited Wanbangde for research and guidance. They were accompanied by Lin Hong, Deputy General Manager of the pharmaceutical group, and Qu Junbiao, another Deputy General Manager.
During the visit, the research team toured the group’s pharmaceutical exhibition hall and gained insights into the company’s core pharmaceutical and medical device businesses, including their operational status, growth milestones, and key flagship products.
During the subsequent symposium, Zhang Fangrong, Chief of the department, first extended a warm welcome on behalf of the Wenling City Administration for Market Regulation to the delegation from the National Institute of Metrology (NIM) who had come to conduct research and provide guidance. He also expressed gratitude to NIM and the provincial/city drug testing institutes for their ongoing support and assistance over the years.
Professor Wang Sijin from the National Institute for Food and Drug Control expressed gratitude to Wanbangde for their strong support of this research initiative. He noted that this visit was a valuable learning journey aimed at brainstorming innovative ideas, fostering mutual exchange, and driving collective growth. Professor Wang also warmly invited Wanbangde to openly share their insights and suggestions on topics such as microbial testing and control of pharmaceutical-grade water, as well as guidelines for ensuring drug sterility.
After hearing a briefing on Wanbande Enterprise’s overview and the status of its pharmaceutical water systems, both parties engaged in an in-depth discussion focusing on aspects such as the design, operation and maintenance, treatment processes, microbial control, conventional sterilization and disinfection methods, daily monitoring strategies, and trend analysis of the pharmaceutical water systems.
After thoroughly reviewing the construction and operational status of the company’s pharmaceutical water system, the research team conducted a site visit to the water production facility and the sterile formulation workshop. They expressed strong appreciation for the company’s meticulous and compliant pharmaceutical water system, as well as the well-organized layout of the workshops.
Pharmaceutical water is a fundamental and critical component in both drug production and quality testing, as its purity directly impacts both drug quality and patient safety. The company has consistently prioritized quality, firmly adhering to the quality philosophy of "Quality First, Robust Systems, Continuous Improvement, and Public Health." From raw material procurement and production process control to product inspection and release, stability studies, and even transportation, every step is rigorously managed to ensure full compliance with regulatory requirements.
Moving forward, the company will maintain high standards and stringent requirements, using this survey as a catalyst to stay committed to steady progress. We will continue to closely monitor and rigorously enforce the safety and compliance of pharmaceutical-grade water, while strengthening our capabilities in pharmaceutical microbiology testing and control technologies. This proactive approach will inject powerful momentum into elevating the company’s quality management system, ultimately contributing smarter, more focused efforts toward shaping a brighter future for human health.
Related Recommendations